JPWO2021075494A1 - - Google Patents
Info
- Publication number
- JPWO2021075494A1 JPWO2021075494A1 JP2021552427A JP2021552427A JPWO2021075494A1 JP WO2021075494 A1 JPWO2021075494 A1 JP WO2021075494A1 JP 2021552427 A JP2021552427 A JP 2021552427A JP 2021552427 A JP2021552427 A JP 2021552427A JP WO2021075494 A1 JPWO2021075494 A1 JP WO2021075494A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019189407 | 2019-10-16 | ||
| PCT/JP2020/038896 WO2021075494A1 (ja) | 2019-10-16 | 2020-10-15 | センタナファジンの製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021075494A1 true JPWO2021075494A1 (ja) | 2021-04-22 |
Family
ID=75538156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552427A Pending JPWO2021075494A1 (ja) | 2019-10-16 | 2020-10-15 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4046687A4 (ja) |
| JP (1) | JPWO2021075494A1 (ja) |
| KR (1) | KR20220083740A (ja) |
| CN (1) | CN114555557A (ja) |
| WO (1) | WO2021075494A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4347564A1 (en) * | 2021-05-31 | 2024-04-10 | Teva Pharmaceuticals International GmbH | Solid state form of centanafadine hcl and process for preparation thereof |
| WO2024048782A1 (en) | 2022-09-02 | 2024-03-07 | Otsuka Pharmaceutical Co., Ltd. | 1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane for treating major depressive disorder |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3807086B2 (ja) * | 1998-03-23 | 2006-08-09 | 味の素株式会社 | 粒度分布制御晶析法 |
| AU765524B2 (en) * | 1999-08-25 | 2003-09-18 | Kansai Chemical Engineering Co., Ltd. | Crystallization apparatus and crystallization method |
| FR2831883B1 (fr) * | 2001-11-08 | 2004-07-23 | Sanofi Synthelabo | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| EP1915146A4 (en) | 2005-07-27 | 2010-06-02 | Dov Pharmaceutical Inc | NOVEL 1-ARYL-3-AZABICYCLO [3.1.0] HEXANEES. PREPARATION AND USE FOR THE TREATMENT OF NEUROPSYCHIATRIC DISEASES |
| ES2922158T3 (es) | 2015-06-17 | 2022-09-09 | Otsuka America Pharmaceutical Inc | Compuestos cristalinos |
| WO2018119291A1 (en) | 2016-12-21 | 2018-06-28 | Otsuka America Pharmaceutical, Inc. | Synthetic methods |
| JP2019147794A (ja) | 2018-02-26 | 2019-09-05 | 大塚製薬株式会社 | 新規製造方法 |
-
2020
- 2020-10-15 JP JP2021552427A patent/JPWO2021075494A1/ja active Pending
- 2020-10-15 KR KR1020227015632A patent/KR20220083740A/ko unknown
- 2020-10-15 CN CN202080072419.1A patent/CN114555557A/zh active Pending
- 2020-10-15 WO PCT/JP2020/038896 patent/WO2021075494A1/ja active Application Filing
- 2020-10-15 EP EP20875801.1A patent/EP4046687A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN114555557A (zh) | 2022-05-27 |
| EP4046687A1 (en) | 2022-08-24 |
| KR20220083740A (ko) | 2022-06-20 |
| EP4046687A4 (en) | 2023-11-15 |
| WO2021075494A1 (ja) | 2021-04-22 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230922 |